Co-treatment with celecoxib or ns398 strongly sensitizes resistant cancer cells to antimitotic drugs independent of p-gp inhibition
- Jong Seung Lim
- , Yujin Park
- , Byung Mu Lee
- , Hyung Sik Kim
- , Sungpil Yoon
- Sungkyunkwan University
Research output: Contribution to journal › Article › peer-review
19
Link opens in a new tab
Scopus
citations